OnKure Therapeutics, Inc. (OKUR) Misses Q4 EPS by 130c

OnKure Therapeutics, Inc. (NASDAQ: OKUR) reported Q4 EPS of ($1.37), $1.30 worse than the analyst estimate of ($0.07).

For earnings history and earnings-related data on OnKure Therapeutics, Inc. (OKUR) click here.

You May Also Be Interested In

• S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
• S&P announces major changes in S&P 100, S&P 500, S&P 400
• Palo Alto Networks, Sandisk, Arista added to S&P 100